You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Treatment-emergent adverse events occurring in Korean and non-Korean subgroup

From: Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women

Adverse event, n (%) Korean subgroup Non-Korean subgroup
FCM (n = 45) FS (n = 44) FCM (n = 78) FS (n = 80)
Any adverse event 27 (60.0) 28 (63.6) 33 (42.3) 22 (27.5)
Severe 0 (0) 0 (0) 0 (0) 2 (2.5)
 Leading to discontinuation 0 (0) 2 (4.5) 1 (1.3) 5 (6.3)
 Outcome of death 0 (0) 0 (0) 0 (0) 0 (0)
Any treatment-related adverse event 4 (8.9) 8 (18.2) 10 (12.8) 11 (13.8)
Severe 0 (0) 0 (0) 0 (0) 1 (1.3)
 Leading to discontinuation 0 (0) 2 (4.5) 1 (1.3) 4 (5.0)
  1. Values with no asterisk have no statistically significant difference when compared with other three values in the same row using Fisher’s exact test
  2. FCM ferric carboxymaltose, FS ferrous sulfate